Home About us Contact
|
Home About us Contact | ||
|
|
||
Effective Elimination (effective + elimination)
Selected AbstractsCover Picture: Electrophoresis 14'09ELECTROPHORESIS, Issue 14 2009Article first published online: 28 JUL 200 Issue no. 14 is an Emphasis Issue with 9 articles on various aspects of "Proteins and Proteomics" while the remaining 14 articles are arranged into 4 different parts including "Microfluidics and Miniaturization", "Genotyping and Transcriptomics", "Enantioseparations", and "Nanoparticles and Abused Drugs Analyses". Selected articles are: Effective elimination of nucleic acids from bacterial protein samples for optimized blue native polyacrylamide gel electrophoresis ((10.1002/elps.200900026)) 2-D difference in gel electrophoresis combined with Pro-Q Diamond staining: A successful approach for the identification of kinase/phosphatase targets ((10.1002/elps.200800780)) Microvalves actuated sandwich immunoassay on an integrated microfluidic system ((10.1002/elps.200800818)) Chemical gradient-mediated melting curve analysis for genotyping of SNPs ((10.1002/elps.200800729)) [source] Effective elimination of nucleic acids from bacterial protein samples for optimized blue native polyacrylamide gel electrophoresisELECTROPHORESIS, Issue 14 2009Jingdan Liang Abstract Nucleic acids remaining within bacterial protein samples from Streptomyces lividans and Escherichia coli were found to interfere significantly with blue native polyacrylamide gel electrophoresis (BN-PAGE), a technique used frequently for analyzing bacterial protein complexes in proteomics studies. We have used ultracentrifugation and/or precipitation of cell lysates with streptomycin sulfate to eliminate nucleic acids from total and/or membrane protein samples. Nucleic acid-binding proteins were first enriched by precipitation with streptomycin sulfate, and contaminating nucleic acids were then eliminated by precipitation by adding polyethyleneimine. The performance of BN-PAGE was found to be dramatically improved by these sample preparation steps. [source] Controlled application and removal of liposomal therapeutics: Effective elimination of pegylated liposomal doxorubicin by double-filtration plasmapheresis in vitroJOURNAL OF CLINICAL APHERESIS, Issue 2 2010Gerhard Pütz Abstract Introduction: Nanoscale particle-based drug delivery systems like long circulating liposomal doxorubicin show unique pharmacokinetic properties and improved toxicity profiles. Liposomal doxorubicin accumulates in tumor tissue due to the enhanced permeation and retention effect, but only a small fraction of a total dose reaches the tumor site. Accumulation of liposomal doxorubicin is much faster in tumor sites than in certain organs where dose limiting adverse effects occur. Finding a way to detoxify the predominant part of a given dose, circulating in the blood after accumulation is completed, will presumably reduce severe side effects during chemotherapy. Methods: Elimination properties of therapeutic used pegylated liposomal doxorubicin (Doxil®/Caelyx®) and therapeutic used double-filtration plasmapheresis systems were evaluated in vitro and in reconstituted human blood. Results: Liposomes can be filtered by appropriate membranes without leakage of doxorubicin up to a pressure of 1 bar. At higher pressures, liposomes (,85 nm) may squeeze through much smaller pores without significant leakage of doxorubicin, whereas decreasing pore size to ,8 nm leads to increased leakage of doxorubicin. With therapeutic used apheresis systems, liposomal doxorubicin can be efficiently eliminated out of buffer medium and reconstituted human blood. No leakage of doxorubicin was detected, even when liposomes were circulating for 48 h in human plasma before apheresis. Conclusions: Convenient apheresis techniques are capable of a safe and efficient elimination of therapeutic used liposomal doxorubicin in an experimental model system. J. Clin. Apheresis, 2010. © 2010 Wiley-Liss, Inc. [source] Prenatal PCB exposure and neurobehavioral development in infants and children: Can the Oswego study inform the current debate?PSYCHOLOGY IN THE SCHOOLS, Issue 6 2004Paul Stewart In the current paper we describe the methodology and results of the Oswego study, in light of D.V. Cicchetti, A.S. Kaufman, and S.S. Sparrow's (this issue) criticisms regarding the validity of the human health/behavioral claims in the PCB literature. The Oswego project began as a replication of the Lake Michigan Maternal Infant Cohort study. Beyond replication of the Michigan findings, the study sought to extend results and conclusions through more comprehensive behavioral assessment, and improved confounder control and analytic methodology. Results over the past 5 years have demonstrated a convincing replication of the Michigan findings. The Michigan cohort reported findings relating Great Lakes fish consumption to performance impairments on the Neonatal Behavioral Assessment Scale (J. Jacobson, S. Jacobson, P. Schwartz, G. Fein, & J. Dowler, 1984). These findings were also found in the Oswego cohort (E. Lonky, J. Reihman, T. Darvill, J. Mather, & H. Daly, 1996), and the Oswego study extended the association to cord blood PCBS (P.W. Stewart, J. Reihman, E. Lonky, and T. Darvill, 2000). The Michigan cohort reported an association between prenatal PCB exposure and poorer performance on the Fagan Test of Infant Intelligence (S.W. Jacobson, G.G. Fein, J.L. Jacobson, P.M. Schwartz, & J.K. Dowler, 1985). The Oswego cohort found similar results (T. Darvill, E. Lonky, J. Reihman, P. Stewart, & J. Pagano, 2000). The Michigan Cohort reported an association between prenatal PCB exposure and performance impairments on the McCarthy Scales of Children's abilities (J. Jacobson & S. Jacobson, 1997). The Oswego study also found PCB-related impairments on the McCarthy Scales (P.W. Stewart, J. Reihman, E. Lonky, T. Darvill, & J. Pagano, 2003). The Oswego results used the same exposure metric in every paper, employed conservative statistical design and analysis, and controlled for more than 40 potentially confounding variables. Moreover, while PCBs were related to all the behavioral endpoints outlined above, alternative candidates for effect, including lead, HCB, Mirex, DDE, and MeHg were not. Taken together, these results support the hypothesis that prenatal PCB exposure results in statistically significant predictors of small, but measurable, deficits in cognitive development from infancy through early childhood. Cicchetti et al. argue that these results, generated by independent investigators, be dismissed because they reflect a combination of measurement error, Type I error, and residual confounding. The evidence Cicchetti et al. present in support of their position fails to explain the nearly identical pattern of associations observed in the Oswego and Michigan Cohorts. In light of this replication, the extensive assessment of potential confounders, the effective elimination of alternative contaminants, and the conservative statistical approach employed in the Oswego study, we find that Cicchetti et al.'s claims are not substantiated. © 2004 Wiley Periodicals, Inc. Psychol Schs 41: 639,653, 2004. [source] Cancer vaccines: Where are we going?ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Issue 2010Jonathan CEBON Abstract The discovery that the immune system can distinguish molecular targets on cancer cells has led to efforts to develop cancer immunotherapeutics that can improve the recognition and effective elimination of tumor cells. Several types of tumor antigens are recognized by T lymphocytes, which are classified according to patterns of gene expression or protein distribution. Of particular interest is the group of molecules known as cancer-germline or cancer-testis antigens. As the relationship between the immune system and cancer has become clearer, so too have the challenges in designing effective cancer immunotherapeutics: (i) antigens need to be specifically selected based on ideal characteristics, such as tissue distribution that is restricted to tumors; (ii) selected antigens need to be combined with adjuvant agents that enhance their immunogenicity and yield robust responses; (iii) vaccination should be timed to pre-empt the development of regulatory suppressive immune mechanisms; and (iv) if suppressive regulatory mechanisms do arise, specific antagonists may be needed to enhance pro-immune outcomes. These challenges are shaping current and future research in this area. [source] | ||||||||||